Does black ethnicity influence the development of stent thrombosis in the drug-eluting stent era?

Circulation

Volumn 122, Issue 11, 2010, Pages 1085-1090

  Collins, Sara D ^a   Torguson, Rebecca ^a   Gaglia, Michael A ^a   Lemesle, Gilles ^a   Syed, Asmir I ^a   Ben Dor, Itsik ^a   Li, Yanlin ^a   Maluenda, Gabriel ^a   Kaneshige, Kimberly ^a   Xue, Zhenyi ^a   Kent, Kenneth M ^a   Pichard, Augusto D ^a   Suddath, William O ^a   Satler, Lowell F ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

drug eluting stents; stents; thrombosis

Indexed keywords

CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ELUTING STENT; DRUG WITHDRAWAL; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; HUMAN; HYPERTENSION; IMPLANTATION; INCOME; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SOCIAL STATUS; STENT THROMBOSIS; TREATMENT DURATION; UNIVARIATE ANALYSIS; ANALOGS AND DERIVATIVES; BLACK PERSON; CAUCASIAN; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; ETHNOLOGY; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; SOCIAL CLASS; THROMBOSIS; TREATMENT OUTCOME;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PLATELET AGGREGATION INHIBITORS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIAL CLASS; THROMBOSIS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 77957278868     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.907998     Document Type: Article

References (34)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R, for the RAVEL Study Group, Randomized Study With the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780.
2. Sousa J. New frontiers in interventional cardiology. Circulation. 2005; 111:671-681.
3. Kuntz RE, Baim DS. Defining coronary restenosis: newer clinical and angiographic paradigms. Circulation. 1993;88:1310-1323.
4. Vaknin-Assa H, Assali A, Ukabi S, Lev EI, Kornowski R. Stent thrombosis following drug-eluting stent implantation: a single-center experience. Cardiovasc Revasc Med. 2007;8:243-247.
5. Ong AT, Hoye A, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Sonnenschein K, Regar E, McFadden EP, Sianos G, van der Giessen WJ, de Jaegere PP, de Feyter P, van Domburg RT, Serruys PW. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol. 2005;45:947-953.
6. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126-2130.
7. Maynard C, Fisher L, Passamani E, Pullum T. Blacks in the Coronary Artery Surgery Study: risk factors and coronary artery disease. Circulation. 1986;74:64-71. (Pubitemid 16092925)
8. Mensah G. State of disparities in cardiovascular health in the United States. Circulation. 2005;111:1233-1241.
9. Haywood L. Issues in the natural history and treatment of coronary heart disease in black populations: medical management. Am Heart J. 1984; 108(pt 2):683-687.
10. Brooks M, Jones R, Bach R, Chaitman B, Kern M, Orszulak T, Follmann D, Sopko G, Blackstone E, Califf R. Predictors of mortality and mortality from cardiac causes in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial and registry. Circulation. 2000;101: 2682-2689.
11. Johnson PA, Lee TH, Cook EF, Rouan GW, Goldman L. Effect of race on the presentation and management of patients with acute chest pain. Ann Intern Med. 1993;118:593-601.
12. Leborgne L, Cheneau E, Wolfram R, Pinnow EE, Canos DA, Pichard AD, Suddath WO, Satler LF, Lindsay J, Waksman R. Comparison of baseline characteristics and one-year outcomes between African-Americans and Caucasians undergoing percutaneous coronary intervention. Am J Cardiol. 2004;93:389-393.
13. Mastoor M, Iqbal U, Pinnow E, Lindsay J Jr. Ethnicity does not affect outcomes of coronary angioplasty. Clin Cardiol. 2000;23:379-382.
14. Garg M, Vacek JL, Hallas D. Coronary angioplasty in black and white patients: demographic characteristics and outcomes. South Med J. 2000; 93:1187.
15. Gaglia M, Steinberg D, Slottow TP, Roy P, Bonello L, Delabriolle A, Lemesle G, Okabe T, Torguson R, Kaneshige K, Xue Z, Suddath W, Kent K, Satler L, Pichard A, Lindsay J, Waksman R. Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stents. Am J Cardiol. 2009;103:653-658.
16. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B, for the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol. 2006;47:216-235.
17. US Census Bureau. Available at: www.census.gov. Accessed February 14, 2008.
18. Wenaweser P, Daemen J, Zwahlen M, Vandomburg R, Juni P, Vaina S, Hellige G, Tsuchida K, Morger C, Boersma E. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice: 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol. 2008;52: 1134-1140.
19. Pinto Slottow T, Steinberg D, Roy P, Buch A, Okabe T, Xue Z, Kaneshige K, Torguson R, Lindsay J, Pichard A. Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period. Am J Cardiol. 2008;102:298-303.
20. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, Kim SW, Bui A, Gevorkian N, Xue Z, Smith K, Fournadjieva J, Suddath WO, Satler LF, Pichard AD, Kent KM, Waksman R. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus-and paclitaxel-eluting stents. Circulation. 2006;113: 1108-1113.
21. Daumit GL, Hermann JA, Coresh J, Powe NR. Use of cardiovascular procedures among black persons and white persons: a 7-year nationwide study in patients with renal disease. Ann Intern Med. 1999;130:173-182.
22. Lutsey PL, Diez Roux AV, Jacobs DR, Burke GL, Harman J, Shea S, Folsom AR. Associations of acculturation and socioeconomic status with subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis. Am J Public Health. 2008;98:1963-1970.
23. Kanjilal S, Gregg EW, Cheng YJ, Zhang P, Nelson DE, Mensah G, Beckles GL. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. Arch Intern Med. 2006;166:2348-2355.
24. Ford E. Coronary arteriography and coronary bypass survey among whites and other racial groups relative to hospital-based incidence rates for coronary artery disease: findings from NHDS. Am J Public Health. 1989;79:437-440.
25. Peterson E, Shaw L, DeLong E, Pryor D, Califf R, Mark D. Racial variation in the use of coronary-revascularization procedures: are the differences real? Do They Matter? N Engl J Med. 1997;336:480-486.
26. McBean AM, Warren JL, Babish JD. Continuing differences in the rates of percutaneous transluminal coronary angioplasty and coronary artery bypass graft surgery between elderly black and white Medicare beneficiaries. Am Heart J. 1994;127:287-295.
27. Whittle J, Conigliaro J, Good CB, Lofgren RP. Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system. N Engl J Med. 1993;329:621-627.
28. Gornick M, Eggers P, Reilly T, Mentnech R, Fitterman L, Kucken L, Vladeck B. Effects of race and income on mortality and use of services among Medicare beneficiaries. N Engl J Med. 1996;335:791-799.
29. Lemesle G, De Labriolle A, Ben-Dor I, Maluenda G, Collins SD, Syed AI, Torguson R, Kaneshige K, Xue Z, Suddath WO, Satler LF, Kent KM, Lindsay J, Pichard AD, Waksman R. Is there a rebound effect after clopidogrel cessation in patients undergoing percutaneous coronary intervention and drug-eluting stent implantation? J Am Coll Cardiol. 2009; 53:A1-A99.
30. Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias W, Braunwald E, Sabatine MS. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med. 2009; 360:354-362.
31. Brandt JT, Close SL, Iturria SJ, Payne CD, Farid NA, Ernest CS, Lachno DR, Salazar D, Winters KJ. Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel. J Thromb Haemost. 2007;5:2429-2436.
32. Desta Z, Zhao X, Shin JG, Flockhart DA. Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin Pharmacokinet. 2002;41:913-958.
33. Geronimus AT, Bound J. Use of census-based aggregate variables to proxy for socioeconomic group: evidence from national samples. Am J Epidemiol. 1998;148:475-486.
34. Danesh J, Gault S, Semmence J, Appleby P, Peto R. Postcodes as useful markers of social class: population based study in 26 000 British households. BMJ. 1999;318:843-844.